NEW YORK, June 10, 2020 /PRNewswire/ -- The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain.Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine.
Read the full report: https://www.reportlinker.com/p05914175/?utm_source=PRN
The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gene-related peptide inhibitors, Platelet rich plasma therapy, Ditans, Hydrogel therapy, and stem cell therapy among several others. The research also provides competitive intelligence across emerging innovators in this space, while provide insights across the patent landscape for non-narcotic pain therapy.
Read the full report: https://www.reportlinker.com/p05914175/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article